Cargando…

Biomarkers for cardiovascular risk prediction: from pioneering to evidence-based use in clinical practice

Detalles Bibliográficos
Autor principal:	Hemels, M. E. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2022
Materias:	Editor’s Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691796/ https://www.ncbi.nlm.nih.gov/pubmed/36378399 http://dx.doi.org/10.1007/s12471-022-01737-0

Ejemplares similares

“When you see a fork in the road, take it”—Yogi Berra
por: Pinto, Yigal M., et al.
Publicado: (2023)

PIONEER trial: favipiravir to treat moderate COVID-19
por: Shalhoub, Sarah
Publicado: (2023)

Circulating ACE2: a novel biomarker of cardiovascular risk
por: Ramchand, Jay, et al.
Publicado: (2020)

Deciphering the response and resistance to immune-checkpoint inhibitors in lung cancer with artificial intelligence-based analysis: when PIONeeR meets QUANTIC
por: Ciccolini, Joseph, et al.
Publicado: (2020)

Emphasis on prevention: how to approach residual cardiovascular risk
por: Cornel, J. H., et al.
Publicado: (2021)

Predicted but not destined: considerations for obesity-related cardiovascular risk projection
por: Wang, Tzung-Dau, et al.
Publicado: (2023)

Barriers to implementation of evidence into clinical practice in low-resource settings
por: Owolabi, Mayowa O., et al.
Publicado: (2022)

Integration of sex and gender in cardiovascular medicine: a scientific and clinical imperative
por: Kavousi, Maryam, et al.
Publicado: (2023)

How to get a smoker addicted to quitting
por: Hemels, M. E. W.
Publicado: (2016)

Stacking of antithrombotic drugs in cardiology: evidence-based customisation
por: Peters, R. J. G.
Publicado: (2022)

Cardiovascular risks of climate change
por: Peters, Annette, et al.
Publicado: (2020)

Polygenic risk scores for prediction of atrial fibrillation
por: Kavousi, Maryam, et al.
Publicado: (2022)

Individual, societal and clinical burden of cardiovascular disease: health technology assessment to guide new diagnostics and treatment strategies
por: van der Velden, Jolanda
Publicado: (2023)

Crown years for non-invasive cardiovascular imaging (Part III): 30 years cardiovascular magnetic resonance
por: van der Wall, E. E.
Publicado: (2013)

Milestones in cardiovascular medicine: 10 or more?
por: van der Wall, E. E.
Publicado: (2013)

Mortality decrease from cardiovascular disease in Europe: 50 % in 30 years!
por: van der Wall, E. E.
Publicado: (2013)

Quantification of biomarker functionality predicts patient outcomes
por: Larijani, Banafshé, et al.
Publicado: (2021)

Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants
por: Walsh, R., et al.
Publicado: (2021)

Inter-arm blood pressure difference, when is it a useful risk marker for cardiovascular events?
por: Clark, Christopher E.
Publicado: (2021)

Impact factor 2012 for cardiovascular journals: true impact?
por: van der Wall, E. E.
Publicado: (2013)

Beta-blocking agents in cardiovascular disease; are they here to stay?
por: van der Wall, E. E.
Publicado: (2014)

Health literacy skills and the benefits of cardiovascular disease prevention
por: Peters, R. J. G.
Publicado: (2017)

Towards evidence-based management of patients treated with cardiotoxic chemotherapy: A collaborative effort of cardiologists and oncologists
por: Leerink, J. M., et al.
Publicado: (2018)

Refocusing SIDS research: Is butylcholinesterase a predictive biomarker?
por: Matthews, Emma
Publicado: (2022)

Will better evidence on clinical utility bring about greater use of (genetic) tests?
por: Hyde, Chris
Publicado: (2021)

Non-obstructive cardiovascular disease: a new challenge for invasive cardiology?
por: Wittekoek, M. E., et al.
Publicado: (2017)

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association
por: Ortiz, Alberto, et al.
Publicado: (2022)

Crown years for noninvasive cardiovascular imaging (part I): 60 years of echocardiography
por: van der Wall, E. E.
Publicado: (2013)

Will polygenic risk scores for cancer ever be clinically useful?
por: Sud, Amit, et al.
Publicado: (2021)

The elusive biomarker
por: Huntingford, Simone, et al.
Publicado: (2022)

Crown years for non-invasive cardiovascular imaging (Part II): 40 years of nuclear cardiology
por: van der Wall, E. E.
Publicado: (2013)

Cardiovascular risks in subjects exposed to the Brumadinho dam collapse, Minas Gerais, Brazil
por: Valenti, Vitor Engrácia, et al.
Publicado: (2019)

Perspectives on validation of clinical predictive algorithms
por: de Hond, Anne A. H., et al.
Publicado: (2023)

Psychiatric pioneers in Yoga therapy
por: Ottilingam, Somasundaram, et al.
Publicado: (2019)

Crown years for non-invasive cardiovascular imaging (Part IV): 30 years of cardiac computed tomography
por: van der Wall, E. E.
Publicado: (2013)

Stroke prevention in patients with atrial fibrillation and comorbidities: evidence and common sense
por: de Groot, J. R.
Publicado: (2020)

Reducing cardiovascular risk caused by air pollution: individuals can make a difference
por: Mahlof, Elliot N., et al.
Publicado: (2020)

Using the Cardio-Ankle Vascular Index (CAVI) or the Mathematical Correction Form (CAVI(0)) in Clinical Practice
por: Alizargar, Javad, et al.
Publicado: (2020)

The International Science and Evidence-based Education Assessment
por: Duraiappah, Anantha, et al.
Publicado: (2021)

Hodgkin Lymphoma: Comments on ESMO Clinical Practice Guidelines
por: Aurer, Igor, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lskleqb6ilbsjkhincmkue4fgi